Logo image of DRX.CA

ADF GROUP INC (DRX.CA) Stock Fundamental Analysis

TSX:DRX - Toronto Stock Exchange - CA00089N1033 - Common Stock - Currency: CAD

8.15  +0.23 (+2.9%)

Fundamental Rating

7

Overall DRX gets a fundamental rating of 7 out of 10. We evaluated DRX against 808 industry peers in the Metals & Mining industry. DRX gets an excellent profitability rating and is at the same time showing great financial health properties. DRX is valued quite cheap, but it does not seem to be growing. These ratings would make DRX suitable for value investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year DRX was profitable.
DRX had a positive operating cash flow in the past year.
Each year in the past 5 years DRX has been profitable.
Of the past 5 years DRX 4 years had a positive operating cash flow.
DRX.CA Yearly Net Income VS EBIT VS OCF VS FCFDRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

1.2 Ratios

DRX has a Return On Assets of 16.78%. This is amongst the best in the industry. DRX outperforms 96.04% of its industry peers.
DRX has a better Return On Equity (30.02%) than 97.15% of its industry peers.
DRX has a better Return On Invested Capital (24.58%) than 98.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for DRX is significantly above the industry average of 12.36%.
The 3 year average ROIC (18.23%) for DRX is below the current ROIC(24.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 16.78%
ROE 30.02%
ROIC 24.58%
ROA(3y)11.8%
ROA(5y)8.76%
ROE(3y)22.9%
ROE(5y)16.89%
ROIC(3y)18.23%
ROIC(5y)13.62%
DRX.CA Yearly ROA, ROE, ROICDRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 17.47%, DRX belongs to the top of the industry, outperforming 94.31% of the companies in the same industry.
DRX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 25.00%, DRX belongs to the top of the industry, outperforming 93.44% of the companies in the same industry.
DRX's Operating Margin has improved in the last couple of years.
DRX has a better Gross Margin (30.62%) than 91.58% of its industry peers.
In the last couple of years the Gross Margin of DRX has grown nicely.
Industry RankSector Rank
OM 25%
PM (TTM) 17.47%
GM 30.62%
OM growth 3Y76.93%
OM growth 5Y146%
PM growth 3Y69.95%
PM growth 5YN/A
GM growth 3Y53.12%
GM growth 5Y28.02%
DRX.CA Yearly Profit, Operating, Gross MarginsDRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so DRX is creating value.
The number of shares outstanding for DRX has been reduced compared to 1 year ago.
The number of shares outstanding for DRX has been reduced compared to 5 years ago.
Compared to 1 year ago, DRX has an improved debt to assets ratio.
DRX.CA Yearly Shares OutstandingDRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DRX.CA Yearly Total Debt VS Total AssetsDRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.22 indicates that DRX is not in any danger for bankruptcy at the moment.
The Altman-Z score of DRX (3.22) is better than 61.14% of its industry peers.
The Debt to FCF ratio of DRX is 0.48, which is an excellent value as it means it would take DRX, only 0.48 years of fcf income to pay off all of its debts.
DRX's Debt to FCF ratio of 0.48 is amongst the best of the industry. DRX outperforms 95.54% of its industry peers.
DRX has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DRX (0.24) is worse than 68.19% of its industry peers.
Even though the debt/equity ratio score it not favorable for DRX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 0.48
Altman-Z 3.22
ROIC/WACC3.11
WACC7.9%
DRX.CA Yearly LT Debt VS Equity VS FCFDRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 2.45 indicates that DRX has no problem at all paying its short term obligations.
With a Current ratio value of 2.45, DRX perfoms like the industry average, outperforming 59.28% of the companies in the same industry.
A Quick Ratio of 2.26 indicates that DRX has no problem at all paying its short term obligations.
DRX has a Quick ratio (2.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 2.26
DRX.CA Yearly Current Assets VS Current LiabilitesDRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

3

3. Growth

3.1 Past

DRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.54%, which is quite good.
Measured over the past years, DRX shows a very strong growth in Earnings Per Share. The EPS has been growing by 84.52% on average per year.
DRX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -19.66%.
DRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.58% yearly.
EPS 1Y (TTM)14.54%
EPS 3Y84.52%
EPS 5YN/A
EPS Q2Q%-35.28%
Revenue 1Y (TTM)-19.66%
Revenue growth 3Y6.55%
Revenue growth 5Y13.58%
Sales Q2Q%-48.3%

3.2 Future

Based on estimates for the next years, DRX will show a very negative growth in Earnings Per Share. The EPS will decrease by -16.18% on average per year.
Based on estimates for the next years, DRX will show a decrease in Revenue. The Revenue will decrease by -8.15% on average per year.
EPS Next Y-45.11%
EPS Next 2Y-16.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-19.84%
Revenue Next 2Y-8.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRX.CA Yearly Revenue VS EstimatesDRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DRX.CA Yearly EPS VS EstimatesDRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2024 2025 2026 2027 0 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

DRX is valuated cheaply with a Price/Earnings ratio of 4.43.
Compared to the rest of the industry, the Price/Earnings ratio of DRX indicates a rather cheap valuation: DRX is cheaper than 97.77% of the companies listed in the same industry.
DRX is valuated cheaply when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.30, the valuation of DRX can be described as very cheap.
95.05% of the companies in the same industry are more expensive than DRX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. DRX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.43
Fwd PE 6.3
DRX.CA Price Earnings VS Forward Price EarningsDRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DRX is valued cheaply inside the industry as 99.50% of the companies are valued more expensively.
99.75% of the companies in the same industry are more expensive than DRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.43
EV/EBITDA 1.31
DRX.CA Per share dataDRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

DRX has an outstanding profitability rating, which may justify a higher PE ratio.
DRX's earnings are expected to decrease with -16.18% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.18%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

DRX has a yearly dividend return of 0.50%, which is pretty low.
Compared to an average industry Dividend Yield of 2.51, DRX pays a better dividend. On top of this DRX pays more dividend than 95.30% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, DRX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

On average, the dividend of DRX grows each year by 8.48%, which is quite nice.
DRX has paid a dividend for at least 10 years, which is a reliable track record.
DRX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.48%
Div Incr Years1
Div Non Decr Years13
DRX.CA Yearly Dividends per shareDRX.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

1.84% of the earnings are spent on dividend by DRX. This is a low number and sustainable payout ratio.
DP1.84%
EPS Next 2Y-16.18%
EPS Next 3YN/A
DRX.CA Yearly Income VS Free CF VS DividendDRX.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M
DRX.CA Dividend Payout.DRX.CA Dividend Payout, showing the Payout Ratio.DRX.CA Dividend Payout.PayoutRetained Earnings

ADF GROUP INC

TSX:DRX (7/2/2025, 7:00:00 PM)

8.15

+0.23 (+2.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)06-10 2025-06-10
Earnings (Next)09-10 2025-09-10
Inst Owners3.51%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap133.50M
Analysts84
Price Target10.2 (25.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.03
Dividend Growth(5Y)8.48%
DP1.84%
Div Incr Years1
Div Non Decr Years13
Ex-Date04-24 2025-04-24 (0.02)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.11%
PT rev (3m)-56.52%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.91%
Valuation
Industry RankSector Rank
PE 4.43
Fwd PE 6.3
P/S 0.46
P/FCF 1.43
P/OCF 1.3
P/B 0.8
P/tB 0.82
EV/EBITDA 1.31
EPS(TTM)1.84
EY22.58%
EPS(NY)1.29
Fwd EY15.86%
FCF(TTM)5.68
FCFY69.73%
OCF(TTM)6.25
OCFY76.68%
SpS17.57
BVpS10.22
TBVpS9.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 16.78%
ROE 30.02%
ROCE 32.03%
ROIC 24.58%
ROICexc 36.97%
ROICexgc 38.17%
OM 25%
PM (TTM) 17.47%
GM 30.62%
FCFM 32.35%
ROA(3y)11.8%
ROA(5y)8.76%
ROE(3y)22.9%
ROE(5y)16.89%
ROIC(3y)18.23%
ROIC(5y)13.62%
ROICexc(3y)24.54%
ROICexc(5y)17.69%
ROICexgc(3y)25.17%
ROICexgc(5y)18.15%
ROCE(3y)23.75%
ROCE(5y)17.74%
ROICexcg growth 3Y78.34%
ROICexcg growth 5Y166.39%
ROICexc growth 3Y78.21%
ROICexc growth 5Y166.39%
OM growth 3Y76.93%
OM growth 5Y146%
PM growth 3Y69.95%
PM growth 5YN/A
GM growth 3Y53.12%
GM growth 5Y28.02%
F-Score7
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 0.48
Debt/EBITDA 0.5
Cap/Depr 148.16%
Cap/Sales 3.22%
Interest Coverage 28.21
Cash Conversion 130.9%
Profit Quality 185.17%
Current Ratio 2.45
Quick Ratio 2.26
Altman-Z 3.22
F-Score7
WACC7.9%
ROIC/WACC3.11
Cap/Depr(3y)162.65%
Cap/Depr(5y)192.31%
Cap/Sales(3y)3.16%
Cap/Sales(5y)3.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.54%
EPS 3Y84.52%
EPS 5YN/A
EPS Q2Q%-35.28%
EPS Next Y-45.11%
EPS Next 2Y-16.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-19.66%
Revenue growth 3Y6.55%
Revenue growth 5Y13.58%
Sales Q2Q%-48.3%
Revenue Next Year-19.84%
Revenue Next 2Y-8.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.2%
EBIT growth 3Y88.52%
EBIT growth 5Y179.4%
EBIT Next Year22.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y174.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y136.12%
OCF growth 3Y174.25%
OCF growth 5YN/A